GMED
Price
$50.26
Change
-$0.49 (-0.97%)
Updated
Sep 25, 6:59 PM EST
44 days until earnings call
STE
Price
$224.72
Change
+$0.74 (+0.33%)
Updated
Sep 25, 11:55 AM EST
45 days until earnings call

Analysis and predictions GMED vs STE

Header iconGMED vs STE Comparison
Open Charts GMED vs STEBanner chart's image
Globus Medical
Price$50.26
Change-$0.49 (-0.97%)
Volume$272K
CapitalizationN/A
STERIS
Price$224.72
Change+$0.74 (+0.33%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
GMED vs STE Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
GMED vs. STE commentary
Sep 25, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a Hold and STE is a StrongSell.

COMPARISON
Comparison
Sep 25, 2023
Stock price -- (GMED: $50.77 vs. STE: $223.94)
Brand notoriety: GMED and STE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GMED: 36% vs. STE: 130%
Market capitalization -- GMED: $7.1B vs. STE: $22.12B
GMED [@Medical Specialties] is valued at $7.1B. STE’s [@Medical Specialties] market capitalization is $22.12B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $6.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green whileSTE’s FA Score has 2 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • STE’s FA Score: 2 green, 3 red.
According to our system of comparison, STE is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 4 TA indicator(s) are bullish while STE’s TA Score has 4 bullish TA indicator(s).

  • GMED’s TA Score: 4 bullish, 4 bearish.
  • STE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, STE is a better buy in the short-term than GMED.

Price Growth

GMED (@Medical Specialties) experienced а +1.52% price change this week, while STE (@Medical Specialties) price change was -2.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.25%. For the same industry, the average monthly price growth was -5.32%, and the average quarterly price growth was -6.87%.

Reported Earning Dates

GMED is expected to report earnings on Nov 08, 2023.

STE is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Medical Specialties (-3.25% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for GMED with price predictions.
OPEN
A.I.dvisor published
a Summary for STE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
STE($22.1B) has a higher market cap than GMED($7.1B). STE has higher P/E ratio than GMED: STE (185.19) vs GMED (25.38). STE YTD gains are higher at: 22.111 vs. GMED (-31.641). STE has higher annual earnings (EBITDA): 852M vs. GMED (318M). GMED has more cash in the bank: 613M vs. STE (209M). STE has higher revenues than GMED: STE (5.09B) vs GMED (1.1B).
GMEDSTEGMED / STE
Capitalization7.1B22.1B32%
EBITDA318M852M37%
Gain YTD-31.64122.111-143%
P/E Ratio25.38185.1914%
Revenue1.1B5.09B22%
Total Cash613M209M293%
Total DebtN/A3.12B-
FUNDAMENTALS RATINGS
GMED vs STE: Fundamental Ratings
GMED
STE
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
10016
SMR RATING
1..100
6687
PRICE GROWTH RATING
1..100
7642
P/E GROWTH RATING
1..100
846
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GMED's Valuation (75) in the Medical Specialties industry is in the same range as STE (88). This means that GMED’s stock grew similarly to STE’s over the last 12 months.

STE's Profit vs Risk Rating (16) in the Medical Specialties industry is significantly better than the same rating for GMED (100). This means that STE’s stock grew significantly faster than GMED’s over the last 12 months.

GMED's SMR Rating (66) in the Medical Specialties industry is in the same range as STE (87). This means that GMED’s stock grew similarly to STE’s over the last 12 months.

STE's Price Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for GMED (76). This means that STE’s stock grew somewhat faster than GMED’s over the last 12 months.

STE's P/E Growth Rating (6) in the Medical Specialties industry is significantly better than the same rating for GMED (84). This means that STE’s stock grew significantly faster than GMED’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMEDSTE
RSI
ODDS (%)
Bullish Trend 4 days ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
53%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
66%
MACD
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
44%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
68%
Bearish Trend 4 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
58%
Bullish Trend 4 days ago
62%
Advances
ODDS (%)
Bullish Trend 7 days ago
66%
Bullish Trend 19 days ago
65%
Declines
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 5 days ago
47%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
72%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
56%
Bearish Trend 4 days ago
43%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DBL14.530.11
+0.76%
Doubleline Opportunistic Credit Fund
UNL10.780.05
+0.44%
United States 12 Month Natural Gas
COMP.X40.2370400.080643
+0.20%
Compound cryptocurrency
FTQI18.910.01
+0.04%
First Trust Nasdaq BuyWrite Income ETF
BWX21.49-0.02
-0.09%
SPDR® Blmbg Intl Trs Bd ETF

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with STE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then STE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
-0.63%
STE - GMED
59%
Loosely correlated
+1.48%
COO - GMED
53%
Loosely correlated
+0.15%
IQV - GMED
52%
Loosely correlated
-0.22%
IDXX - GMED
52%
Loosely correlated
-0.67%
ZBH - GMED
52%
Loosely correlated
-0.81%
More

STE and

Correlation & Price change

A.I.dvisor indicates that over the last year, STE has been loosely correlated with GMED. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if STE jumps, then GMED could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STE
1D Price
Change %
STE100%
+1.48%
GMED - STE
60%
Loosely correlated
-0.63%
SYK - STE
59%
Loosely correlated
+0.29%
RVTY - STE
54%
Loosely correlated
+0.93%
COO - STE
54%
Loosely correlated
+0.15%
IQV - STE
53%
Loosely correlated
-0.22%
More